Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Lawmaker pitches Bill 859 to study and support clinical psychedelic trials in Vermont
Summary
Sponsor introduced Bill 859 to recreate a psychedelic therapy advisory board and explore joining a multi-state consortium to enable clinical drug development trials (including Ibogaine); members discussed funding, referral to Human Services, and possibly splitting controversial trial provisions from study work.
Unidentified Speaker 4 outlined Bill 859 as "an act relating to psychedelic therapy and clinical drug development trials," saying the measure would recreate and empower the prior advisory working group and explore a partnership with a 13-state consortium led by Texas to pursue FDA clinical trials. Speaker 4 framed the bill as study and trial-enabling rather than legalization: "the bill does not legalize psychedelic medicines... it has the board explore ways to safely implement clinical…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
